0
Abstract: Slide Presentations |

UTILITY OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION IN THE DIAGNOSIS OF MEDIASTINAL MASSES OF UNKNOWN ORIGIN FREE TO VIEW

Kazuhiro Yasufuku, MD, PhD*; Takahiro Nakajima, MD; Taiki Fujiwara, MD; Masako Chiyo, MD, PhD; Akira Iyoda, MD, PhD; Shigetoshi Yoshida, MD, PhD; Makoto Suzuki, MD, PhD; Yasuo Sekine, MD, PhD; Kiyoshi Shibuya, MD, PhD
Author and Funding Information

Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan


Chest


Chest. 2007;132(4_MeetingAbstracts):465a. doi:10.1378/chest.132.4_MeetingAbstracts.465a
Text Size: A A A
Published online

Abstract

PURPOSE: The purpose of the current study was to investigate the clinical utility of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of mediastinal masses in the absence of known pulmonary malignancy.

METHODS: 108 patients with mediastinal masses of unknown origin were included in the study. The convex probe EBUS (Olympus, Japan) integrated with a convex scanning probe on its tip was used for EBUS-TBNA. Final diagnoses were determined by EBUS-TBNA, surgery and/or clinical follow-up. EBUS-TBNA results were classified into 2 categories: (1) malignant mediastinal and (2) benign mediastinal.

RESULTS: The mean age of the group was 56.7 years. The final diagnosis was available in all 108 patients by means of EBUS-TBNA, surgery, mediastinoscopy, other diagnostic or long term follow up. The final diagnoses were 32 malignant mediastinal (12 malignant lymphoma, 5 adenocarcinoma of unknown primary, 4 metastatic, 6 lung cancer, 2 thymic cancer, 1 thymoma, 1 germ cell tumor, 1 chondrosarcoma) and 76 benign mediastinal (38 sarcoidosis, 17 mediastinal cyst, 5 mediastinal goiter, 1 neurogenic tumor, 1 tuberculosis, 1 amyloidosis, 13 nonspecific inflammatory). EBUS-TBNA was diagnostic in 99 of 108 patients (91.7%) for all disease categories (malignant 84.4%, benign 94.7%). EBUS-TBNA was successful in directing subsequent workup and/or therapy in 74 of 108 patients (68.5%).EBUS-TBNA was uneventful and there were no complications.

CONCLUSION: The diagnostic yield of EBUS-TBNA in the assessment of mediastinal masses of unknown origin is very high. There were no complications associated with the procedure. It spares more invasive procedures for tissue sampling of the mediastinum.

CLINICAL IMPLICATIONS: EBUS-TBNA is a safe and minimally invasive approach for sampling of mediastinal tissues. It spares invasive procedures for tissue sampling of the mediastinum which is beneficial for patients with mediastinal masses of unknown origin.

DISCLOSURE: Kazuhiro Yasufuku, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 23, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543